TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
99,435
|
87,811
|
44,956 |
Financial expenses |
1
|
5
|
3 |
Earnings before taxes |
17,435
|
17,414
|
-817 |
EBITDA |
20,191
|
19,439
|
532 |
Total assets |
73,149
|
55,689
|
29,855 |
Current assets |
53,268
|
33,319
|
19,471 |
Current liabilities |
26,234
|
23,615
|
11,392 |
Equity capital |
45,955
|
32,075
|
18,463 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
4
|
3
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.8%
|
57.6%
|
61.8% |
Turnover per employee |
24,859
|
29,270 | |
Profit as a percentage of turnover |
17.5%
|
19.8%
|
-1.8% |
Return on assets (ROA) |
23.8%
|
31.3%
|
-2.7% |
Current ratio |
203.0%
|
141.1%
|
170.9% |
Return on equity (ROE) |
37.9%
|
54.3%
|
-4.4% |
Change turnover |
11,171
|
46,497
|
6,497 |
Change turnover % |
13%
|
113%
|
17% |
Chg. No. of employees |
1
|
3
|
0 |
Chg. No. of employees % | 33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.